 | Up a level |
Paton, Nicholas I. and Gurumurthy, Meera and Lu, Qingshu and Leek, Francesca and Kwan, Philip and Koh, Hiromi W. L. and Molton, James and Mortera, Lalaine and Naval, Sullian and Abu Bakar, Zamzurina and Pang, Yong-Kek and Lum, Lionel and Lim, Tow Keang and Cross, Gail B. and Lekurwale, Ganesh and Choi, Hyungwon and Au, Veonice and Connolly, John and Hibberd, Martin and Green, Justin A. and Team, Pascolizumab TB Trial (2024) Adjunctive Pascolizumab in Rifampicin-Susceptible Pulmonary Tuberculosis: Proof-of-Concept, Partially-Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Trial. Journal of Infectious Diseases, 230 (3). pp. 590-597. ISSN 0022-1899, DOI https://doi.org/10.1093/infdis/jiae104.
